Showing Results for: “diabetes exercise”

Update on SCORED and SOLOIST trials shows reduction in cardiovascular events and stroke using glucose-lowering agents Results from two large clinical trials show significant and early benefits from sotagliflozin, a drug that inhibits sodium-glucose transport protein 2 (SGLT2) and sodium-glucose transport protein 1 (SGLT1) in reducing heart failure, heart attack, and stroke—major problems in people with diabetes. The findings were presented at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Patients with diabetes are at an increased risk of life-threatening

Leading diabetes researchers and clinicians from around the world highlight impact of health disparities on diabetes care The American Diabetes Association® (ADA) is highlighting the latest understanding of how to address health disparities laid bare by the pandemic at the virtual 81st Scientific Sessions. Taking place June 25–29, the ADA’s Scientific Sessions is the world’s largest scientific meeting focused on diabetes research, prevention, and care. These expert discussions come at a time when 76% of Americans currently living in poverty are people of color. Diabetes prevalence is inversely

Consensus report outlines the positive impact of diabetes self-management education and support and the critical need for increased access Seven leading diabetes organizations issued a consensus report today highlighting the value of diabetes self-management education and support (DSMES) services as part of comprehensive diabetes medical care. The report provides compelling evidence for the need for increased utilization of DSMES, four key times that DSMES is most beneficial, and specific recommendations for both clinicians and health systems to increase access to and participation in DSMES

Tracey D. Brown, Chief Executive Officer of the American Diabetes Association (ADA), issued the following statement in response to the unprecedented number of Members of Congress who invited people living with diabetes to join them at President Donald J. Trump’s State of the Union address: “Tonight, at least 13 Members of Congress will host their constituents that are living with diabetes, and who represent the seven million Americans dependent on insulin, at the State of the Union address. They will elevate the voices of all people with diabetes and their families, many of whom struggle to

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk, according to results announced at the symposium titled “Oral Semaglutide—The PIONEER Program Trials” today at the American Diabetes Association’s® (ADA) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. Oral semaglutide reduced cardiovascular death and all-cause mortality by nearly 50 percent, based on median follow up of 15.9 months. PIONEER 6 was conducted across 21 countries and included 3,183 participants who were randomized

Today, the American Diabetes Association® (ADA) and Blue Cross and Blue Shield of Minnesota announced a new endeavor to address disparities in maternal health care delivery, with an emphasis on the impact of gestational diabetes (GDM)—diabetes that occurs during pregnancy. A new professional education series will seek to eliminate provider biases and encourage implementation of the ADA’s Standards of Care in Diabetes (Standards of Care) to optimize maternal and infant health outcomes. GDM affects up to 9% of pregnancies in the U.S. and carries health risks for both mothers and children during

The ADA will work with AWS to revamp their data architecture to enable the advancement of the ADA’s mission Today, the American Diabetes Association® (ADA) announced it has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant , a public grant opportunity open to registered charities in the United Kingdom and Ireland and registered 501(c) nonprofit organizations in the United States who are using technology to solve the world’s most pressing challenges. The grant will support the ADA's efforts to revamp its data architecture to boost donation revenue which will enable

The American Diabetes Association® (ADA) applauds Illinois Governor J.B. Pritzker for signing legislation (Senate Bill 3414) allowing a broader population of Illinois’ Medicaid beneficiaries to be eligible for a continuous glucose monitor (CGM), closing a significant health equity gap in access to care for people with diabetes who are insulin dependent. CGMs continually monitor blood glucose (blood sugar), giving real-time updates through a device that is attached to a person’s body. People with diabetes who use a CGM have fewer instances of hypoglycemia (low blood glucose) and can achieve a

Every generation on my mom's side has/had type 2 diabetes. It's unreal how people don't understand the damage diabetes can do to your body. It can affect almost every organ. My mom had glaucoma, retinopathy, needed a kidney transplant, and had portions of her foot amputated. My mom passed when she was 53 due to complications with diabetes. Past relatives also had amputations of the feet and legs. I just didn't realize the extent of the damage from diabetes until I was diagnosed. I am using what my family members went through to monitor my health. It's been rough, but I am trying. I take 15

The American Diabetes Association ® (ADA) applauds Colorado Governor Jared Polis for signing a bill allowing a broader population of Colorado’s Medicaid members to be eligible for a continuous glucose monitor (CGM), closing a huge health equity gap in access to care for people with diabetes who take insulin. CGMs consistently monitor blood glucose levels (blood sugar), giving real-time updates through a device that is attached to a person’s body. People with diabetes who use a CGM have fewer instances of hypoglycemia (low blood glucose) and can achieve a lower A1C, an important indicator of